11 Best Canadian Stocks to Buy Now
Canada’s stock market offers exposure to businesses whose fortunes can move in very different directions under the same economic conditions.
Xenon Pharmaceuticals Inc. (XENE)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 29 | $1,079 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.32 | 15,000 | $559,740.00 | 15,000 | 2026-09-30 | Filing | |
| $37.38 | 30,000 | $1,121,400.00 | 49,923 | 2026-09-30 | Filing | |
| $28.81 | 700 | $20,167.00 | 700 | 2022-01-21 | Filing | |
| $24.40 | 4,000 | $97,600.00 | 4,000 | 2021-12-06 | Filing | |
| $2.22 | 15,000 | $33,280.50 | 44,210 | 2017-11-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $60.98 | 700 | $42,683.62 | 2 | 2026-08-28 | Filing | |
| $60.17 | 6,368 | $383,145.37 | 702 | 2026-08-28 | Filing | |
| $64.06 | 10,000 | $640,550.00 | 1,870 | 2026-08-11 | Filing | |
| $53.14 | 1,322 | $70,251.08 | 24,896 | 2026-06-05 | Filing | |
| $53.14 | 1,190 | $63,236.60 | 1,455 | 2026-06-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,468,072 | $54,611,522 | 0.05% | |
| 2. | 1,386,148 | $51,546,312 | 0% | |
| 3. | 568,800 | $21,153,672 | 2% | |
| 4. | 472,443 | $17,570,155 | 0% | |
| 5. | 461,498 | $17,225,819 | 0.08% |
News See All
10 Best Biotech Stocks to Invest In According to Billionaires
The race to secure the next blockbuster medicine is giving biotech investors two opportunities to assess: the value a treatment could generate and the price a larger drugmaker might pay to acquire it.
Insiders Are Buying These 2 ‘Strong Buy’ Stocks With Over 60% Upside
Insider activity can provide investors with useful clues about how corporate leaders view their own companies. Executives and directors have firsth...
Xenon Pharmaceuticals (XENE) Seeks Epilepsy Approval. Can its Drug Overcome a Depression Setback?
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) advanced its epilepsy program while encountering a new obstacle to expansion. On September 17, it submitted a New Drug Application to the U.S.
Xenon (XENE) Heads To Europe With Data That Could Reshape Epilepsy Care
On August 26, Xenon Pharmaceuticals (NASDAQ:XENE) announced that it will deliver six data presentations at the 16th European Epilepsy Congress in Athens, Greece, running September 5 through 9.
10 Best Performing Canadian Stocks So Far in 2026
In this article, we will look at the 10 Best Performing Canadian Stocks So Far in 2026. Canadian stocks have moved back into the conversation as investors look beyond the narrow U.S.
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2026 Earnings Call Transcript
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2026 Earnings Call Transcript May 7, 2026Xenon Pharmaceuticals Inc. reports earnings inline with expectations.
10 Best 52-Week High US Stocks to Buy
In this article, we will discuss the 10 Best 52-Week High US Stocks to Buy.
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) is one of the 10 Stocks Making Huge Moves this Week.
10 Stocks Making Huge Moves this Week: Fastly, Sasol, Hims and More
Ten stocks capped off the trading week delivering double-digit gains, despite the broader market suffering turmoil from the ongoing tensions in the Middle East.
Hedge Fund Resource Center